Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligonucleotide analogues: an overview

M Matteucci1

  • 1Gilead Sciences Inc., Foster City, CA 94404, USA.

Ciba Foundation Symposium
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Medicinal chemistry advances improve antisense oligonucleotides, but phosphorothioate linkages remain key for RNA targeting. Enhancements focus on RNase H recruitment and cellular penetration for therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuscany Sangiovese grape juice imparts cardioprotection by regulating gene expression of cardioprotective C-type natriuretic peptide.

European journal of nutrition·2019
Same author

<i>Shewanella algae</i> infection in Italy: report of 3 years' evaluation along the coast of the northern Adriatic Sea.

New microbes and new infections·2018
Same author

First report of sepsis due to Catabacter hongkongensis in an Italian patient.

New microbes and new infections·2016
Same author

An averaging technique for the P300 spatial distribution.

Methods of information in medicine·2015
Same author

Dipyridamole-induced C-type natriuretic peptide mRNA overexpression in a minipig model of pacing-induced left ventricular dysfunction.

Peptides·2015
Same author

Cold perception and gene expression differ in Olea europaea seed coat and embryo during drupe cold acclimation.

The New phytologist·2012
Same journal

Precision agriculture: spatial and temporal variability of environmental quality. General reflections.

Ciba Foundation symposium·1997
Same journal

Uncertainty in hydrogeological modelling.

Ciba Foundation symposium·1997
Same journal

Optimal mapping of site-specific multivariate soil properties.

Ciba Foundation symposium·1997
Same journal

Modelling for precision weed management.

Ciba Foundation symposium·1997
Same journal

GIS support for precision agriculture: problems and possibilities.

Ciba Foundation symposium·1997
Same journal

Spatial sampling.

Ciba Foundation symposium·1997
See all related articles

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oligonucleotide Therapeutics

Background:

  • Antisense and antigene oligonucleotides are key tools in molecular biology and drug development.
  • Significant research has focused on chemical modifications to improve oligonucleotide efficacy.
  • The phosphorothioate linkage is widely used but has limitations.

Purpose of the Study:

  • To review advancements in medicinal chemistry for antisense and antigene oligonucleotides.
  • To evaluate the impact of various modifications on oligonucleotide properties and biological activity.
  • To discuss the current understanding and challenges in oligonucleotide-based therapeutics.

Main Methods:

  • Synthesis and characterization of phosphate, ribose, and base analogues.

Related Experiment Videos

  • Assessment of RNA binding affinity (Tm) and biological effects.
  • Investigation of RNase H recruitment and cellular permeability.

    • Main Results:

    • Phosphorothioate linkage remains the preferred choice despite efforts to find alternatives.
    • Phosphate and ribose modifications enhance RNA binding but show limited biological impact.
    • Chimeric strategies and base modifications improve potency and overcome limitations.

    Conclusions:

    • RNase H recruitment is crucial for potent oligonucleotide activity, with most modifications hindering this.
    • Chimeric strategies offer a way to retain RNase H activity while improving oligonucleotide properties.
    • Cellular permeability remains a critical, controversial factor for the clinical success of oligonucleotide therapeutics.